Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sundan

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Experimental Cell Research|August 1, 1985
Receptor-mediated endocytosis of a ricin-colloidal gold conjugate in vero cells. Intracellular routing to vacuolar and tubulo-vesicular portions of the endosomal systemB van Deurs, L R Pedersen, A Sundan, et al.
Cytokine|January 1, 1993
Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferationB Naume, M K Gately, B B Desai, et al.
The Journal of Biological Chemistry|October 4, 1996
Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell linesM Borset, E Lien, T Espevik, et al.
Blood|February 3, 1998
Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study GroupC Seidel, M Børset, I Turesson, et al.
Human Reproduction (Oxford, England)|November 1, 1993
High concentrations of the soluble p55 tumour necrosis factor receptor in human seminal plasmaN B Liabakk, E Lien, A Sundan, et al.
Leukemia|May 21, 2010
Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitroS Jönsson, H Hjorth-Hansen, B Olsson, et al.
Cytokine|July 1, 1992
Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancementO L Brekke, M R Shalaby, A Sundan, et al.
The Journal of Experimental Medicine|November 1, 1990
Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptorsM R Shalaby, A Sundan, H Loetscher, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1999
The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosisJ Haux, A C Johnsen, B Steinkjer, et al.
Infection and Immunity|May 1, 1993
Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha inductionM Otterlei, A Sundan, G Skjåk-Braek, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Experimental Cell Research|August 1, 1985
Receptor-mediated endocytosis of a ricin-colloidal gold conjugate in vero cells. Intracellular routing to vacuolar and tubulo-vesicular portions of the endosomal systemB van Deurs, L R Pedersen, A Sundan, et al.
Cytokine|January 1, 1993
Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferationB Naume, M K Gately, B B Desai, et al.
The Journal of Biological Chemistry|October 4, 1996
Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell linesM Borset, E Lien, T Espevik, et al.
Blood|February 3, 1998
Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study GroupC Seidel, M Børset, I Turesson, et al.
Human Reproduction (Oxford, England)|November 1, 1993
High concentrations of the soluble p55 tumour necrosis factor receptor in human seminal plasmaN B Liabakk, E Lien, A Sundan, et al.
Leukemia|May 21, 2010
Second-generation TKI dasatinib inhibits proliferation of mesenchymal stem cells and osteoblast differentiation in vitroS Jönsson, H Hjorth-Hansen, B Olsson, et al.
Cytokine|July 1, 1992
Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancementO L Brekke, M R Shalaby, A Sundan, et al.
The Journal of Experimental Medicine|November 1, 1990
Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptorsM R Shalaby, A Sundan, H Loetscher, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1999
The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosisJ Haux, A C Johnsen, B Steinkjer, et al.
Infection and Immunity|May 1, 1993
Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha inductionM Otterlei, A Sundan, G Skjåk-Braek, et al.
Pageof 8